AI Terminal
Aladdin Healthcare Technologies SE
Regulatory Filings • Apr 29, 2020
23_rns_2020-04-29_25242281-d4d7-4a81-b36b-e68494f60e31.html
Regulatory Filings
Open in ViewerOpens in native device viewer
News Details
Ad-hoc | 29 April 2020 12:45
Aladdin Healthcare Technologies sets up Joint Venture with Chinese partner network and wins new customer – first sales revenues of EUR 120,000
Aladdin Healthcare Technologies SE / Key word(s): Joint Venture
Aladdin Healthcare Technologies sets up Joint Venture with Chinese partner network and wins new customer – first sales revenues of EUR 120,000
29-Apr-2020 / 12:45 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Aladdin Healthcare Technologies sets up Joint Venture with Chinese partner network and wins new customer – first sales revenues of EUR 120,000
BERLIN/LONDON , April 29, 2020 – Aladdin Healthcare Technologies SE (“Aladdin”, ISIN: DE000A12ULL2 ), a leading developer of AI healthcare diagnostics and drug discovery applications, has just founded Aladdin Healthcare Technologies China Ltd. together with an extensive network of scientists, pharmacologists and healthcare practitioners including IIAT.
The goal of the joint venture (JV), in which Aladdin Healthcare holds a 51% stake, is the further global development and marketing of an AI-based drug discovery tool. The tool supports basic clinical research for the development of new drugs for age-related diseases such as Alzheimer’s, cardiovascular diseases, pulmonary diseases, diabetes and osteoporosis.
At the same time, Aladdin has gained a new customer. The order volume for the use of the AI platform and for consultancy services is EUR 120,000.
For further information
Aladdin Healthcare Technologies Ltd.
24-26 Baltic Street West
London EC1Y 0UR
Phone +44 7714 719696
Email: [email protected]
Website Link: www.aladdinid.com
Contact Press
CROSS ALLIANCE communication GmbH
Susan Hoffmeister
Phone +49 89 1250 90330
Email: [email protected]
29-Apr-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
| Language: | English |
| Company: | Aladdin Healthcare Technologies SE |
| Unter den Linden 10 | |
| 10117 Berlin | |
| Germany | |
| Phone: | 030 700140449 |
| E-mail: | [email protected] |
| Internet: | www.aladdinid.com |
| ISIN: | DE000A12ULL2 |
| WKN: | A12ULL |
| Listed: | Regulated Market in Dusseldorf |
| EQS News ID: | 1032909 |
| End of Announcement | DGAP News Service |